UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
| Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
| Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
| Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
| Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
| P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
| Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
| Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
| Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |